Erie County Medical Center-Affliate of SUNYat Buffalo — Buffalo, New York

Erie County Medical Center-Affliate of SUNYat Buffalo is a clinical research site located in Buffalo, New York, United States 14215.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Erie County Medical Center-Affliate of SUNYat Buffalo has participated in 2 clinical trials.

Therapeutic areas: Necrotizing Soft Tissue Infections, Necrotizing Fasciitis, Fournier's Gangrene.

Sponsors: Atox Bio Ltd.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Buffalo

Browse all research sites in New York · View every site in Buffalo

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Erie County Medical Center-Affliate of SUNYat Buffalo?

Erie County Medical Center-Affliate of SUNYat Buffalo has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Erie County Medical Center-Affliate of SUNYat Buffalo conducted?

Erie County Medical Center-Affliate of SUNYat Buffalo has 2 clinical trials on record. Their work covers Necrotizing Soft Tissue Infections, Necrotizing Fasciitis, Fournier's Gangrene.

Is Erie County Medical Center-Affliate of SUNYat Buffalo accredited by Crixeo Clinical Trials?

Erie County Medical Center-Affliate of SUNYat Buffalo has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Erie County Medical Center-Affliate of SUNYat Buffalo?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.